Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce D Walker

Showing results (201-210 of 490) with videos related to

Pageof 49
Sort By:
Vaccine|April 20, 2013
Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of VaccinesWayne C Koff, Nina D Russell, Mark Walport, et al.
AIDS Research and Human Retroviruses|February 4, 2011
Short communication: CD8(+) T cell polyfunctionality profiles in progressive and nonprogressive pediatric HIV type 1 infectionChristina F Thobakgale, Hendrik Streeck, Nompumelelo Mkhwanazi, et al.
Plos Pathogens|August 15, 2014
Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytesRichard Brad Jones, Rachel O'Connor, Stefanie Mueller, et al.
Journal of the International AIDS Society|December 13, 2016
Increased frequencies of CD8<sup>+</sup>CD57<sup>+</sup> T cells are associated with antibody neutralization breadth against HIV in viraemic controllersChristine D Palmer, Marisol Romero-Tejeda, Eileen P Scully, et al.
AIDS (London, England)|April 18, 2003
Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infectionCecile L Tremblay, Jennifer L Hicks, Lorraine Sutton, et al.
AIDS Research and Human Retroviruses|April 13, 2010
Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adultsAmbrose H W Wong, Katie Williams, Sharon Reddy, et al.
AIDS (London, England)|April 6, 2018
Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activityAmy W Chung, Jenniffer M Mabuka, Bongiwe Ndlovu, et al.
Journal of Virology|April 13, 2012
Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infectionChristina F Thobakgale, Lena Fadda, Kimberly Lane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South AfricaVincent C Marconi, Henry Sunpath, Zhigang Lu, et al.
Journal of Virology|January 11, 2008
Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activityAviva Joseph, Jian Hua Zheng, Antonia Follenzi, et al.
Pageof 49

Showing results (201-210 of 490) with videos related to

Sort By:
Pageof 49
Vaccine|April 20, 2013
Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of VaccinesWayne C Koff, Nina D Russell, Mark Walport, et al.
AIDS Research and Human Retroviruses|February 4, 2011
Short communication: CD8(+) T cell polyfunctionality profiles in progressive and nonprogressive pediatric HIV type 1 infectionChristina F Thobakgale, Hendrik Streeck, Nompumelelo Mkhwanazi, et al.
Plos Pathogens|August 15, 2014
Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytesRichard Brad Jones, Rachel O'Connor, Stefanie Mueller, et al.
Journal of the International AIDS Society|December 13, 2016
Increased frequencies of CD8<sup>+</sup>CD57<sup>+</sup> T cells are associated with antibody neutralization breadth against HIV in viraemic controllersChristine D Palmer, Marisol Romero-Tejeda, Eileen P Scully, et al.
AIDS (London, England)|April 18, 2003
Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infectionCecile L Tremblay, Jennifer L Hicks, Lorraine Sutton, et al.
AIDS Research and Human Retroviruses|April 13, 2010
Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adultsAmbrose H W Wong, Katie Williams, Sharon Reddy, et al.
AIDS (London, England)|April 6, 2018
Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activityAmy W Chung, Jenniffer M Mabuka, Bongiwe Ndlovu, et al.
Journal of Virology|April 13, 2012
Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infectionChristina F Thobakgale, Lena Fadda, Kimberly Lane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South AfricaVincent C Marconi, Henry Sunpath, Zhigang Lu, et al.
Journal of Virology|January 11, 2008
Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activityAviva Joseph, Jian Hua Zheng, Antonia Follenzi, et al.
Pageof 49